Voyager Therapeutics, Inc (VYGR) with a decrease of 13.4%. Received feedback from the US Food and Drug Administration (FDA) on the investigational new drug (IND) submission for VY-HTT01 for the treatment of Huntington’s disease. 

Inventina (IVA) with an increase of 9.8%. Revealed that the US Food and Drug Administration (FDA) has allowed Breakthrough Therapy appointment to lanifibranor, the Company’s main drug candidate, for the treatment of NASH.

The Walt Disney Company (DIS) with an increase of 4.5%. In the spotlight of the outstanding success acquired to date in the Company’s direct-to-consumer business and to extend acceleration in its DTC strategy. The Walt Disney Company (DIS) today revealed a strategic rearrangement of its media and entertainment businesses. 

Workhorse Group (WKHS) with an increase of 2.6%. Tomorrow is D-day for the $8.1B USPS contract. Additionally, partner company Diamond Peak Holdings (DPHC) was launched with a Buy rating and $50 price target after-hours.